Key Takeaways
- Major indexes saw gains this week despite late-week investor caution.
- AI dealmaking significantly boosted chipmaker Broadcom and retailer Walmart shares.
- The health sector reacted to new care services and President Trump's drug cost comments.
- The six largest U.S. banks reported robust combined profits, increasing 19% year-over-year.
Deep Dive
- The Dow Jones Industrial Average gained 1.6%, the S&P 500 rose 1.7%, and the Nasdaq Composite increased by 2.1% for the week.
- Initial market gains were driven by eased trade war fears with China and strong bank earnings reports.
- Investor sentiment was later tempered by concerns regarding regional banks.
- Broadcom shares jumped 9.9% on Monday following a multi-billion dollar deal with OpenAI for custom AI chips.
- OpenAI also partnered with Walmart for in-chatbot purchases.
- Walmart shares rose 5% on Tuesday and 5.8% for the week due to the OpenAI collaboration.
- Hims & Hers shares surged 16% on Wednesday after announcing new menopause and perimenopause care services.
- The company expects its women's health unit revenue to exceed $1 billion next year due to this expansion.
- President Trump's comments on potential $150 out-of-pocket costs for weight-loss drugs negatively impacted pharmaceutical stocks.
- Novo Nordisk shares fell 4.5% for the week, and Eli Lilly's stock dropped 3.7% for the week following Trump's remarks.
- The six largest U.S. banks reported nearly $41 billion in combined profits, a 19% increase year-over-year.
- Wells Fargo led the gains, with its shares rising 7.3% for the week.
- Bank of America, Morgan Stanley, and Citigroup also finished the week higher.
- Goldman Sachs and JPMorgan Chase experienced slight declines in their stock prices.